HIKMA PHARMACEUTICALS (HKMPF) Financials
HKMPF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 4.7 billion | 2.5 billion |
| 2023-06-30 | 4.6 billion | 2.4 billion |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 4.5 billion | 2.3 billion |
HKMPF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-06-30 | 81.3 million | 10.0 million |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 224.8 million | 12.0 million |
HKMPF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 29.5 million |
| 2023-06-30 | 134.8 million |
| 2023-03-31 | 65.5 million |
| 2022-12-31 | 15.4 million |
HKMPF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 205.0 million | - | 66.0 million |
| 2023-06-30 | 294.0 million | - | 69.0 million |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 270.0 million | - | 70.0 million |
HKMPF Shares Outstanding
HKMPF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-06-30 | 110.1 million | 65.9 million | - | - |
| 2023-03-31 | 42.0 million | - | - | - |
| 2022-12-31 | 120.7 million | 77.2 million | - | - |
HKMPF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-06-30 | 1.5 billion | 758.6 million |
| 2023-03-31 | - | - |
| 2022-12-31 | 1.3 billion | 732.3 million |
HKMPF
Price: $24.50
Dividend Yield: 0.03%
Forward Dividend Yield: 3.84%
Payout Ratio: 110.59%
Dividend Per Share: 0.94 USD
Earnings Per Share: 0.85 USD
P/E Ratio: 35.85
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 5.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 13
DGR3: -5.62%
DGR5: 17.43%
DGR10: 16.71%